xIPOmeter
Pathos
Pathos is a clinical-stage biotechnology company harnessing advanced AI to revolutionize drug development. Their PathOS™ platform leverages real-world oncology and genomic data to create precision medicines through strategic partnerships.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Pathos13
PathosPathos AI, 55 milyon dolarlık Tempus anlaşması imzaladı
Bristol Myers Squibb, Pathos'un E Serisi finansman turuna liderlik ediyor. İlaç şirketi, Pathos'un yapay zeka platformu Pathos Foundry'ye araştırma ve ...
https://tr.investing.com/news/company-news/pathos-ai-55-milyon-dolarlk-tempus-anlasmas-imzalad-93CH-4117733PathosTempus AI enters data licensing agreements with BMS and Pathos ...
For the neurology data, Tempus will deliver and license to Pathos up to 500,000 de-identified records of patients with Alzheimer's disease or other neurological ...
https://ng.investing.com/news/stock-market-news/tempus-ai-enters-data-licensing-agreements-with-bms-and-pathos-ai-worth-1925-million-93CH-2754725PathosAI drug development startup Pathos AI closes $237M investment
Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the ...
https://siliconangle.com/2026/10/23/ai-drug-development-startup-pathos-ai-closes-237m-investment/PathosBristol, Tempus AI partnering with Pathos AI to advance neurological ...
Bristol Myers Squibb (BMY) will collaborate with Pathos AI to utilize the latter's agentic AI platform, Foundry, to build a specialized, curated dataset and ...
https://seekingalpha.com/news/4656853-bristol-tempus-ai-partnering-pathos-ai-advance-neurological-treatmentsPathosPathos AI teams up with Bristol Myers and Tempus AI to advance ...
Oct 23 (Reuters) - Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial ...
https://www.streetinsider.com/General+News/Pathos+AI+teams+up+with+Bristol+Myers+and+Tempus+AI+to+advance+drug+development/27225661.html
Show more (8)Investors1
New Enterprise Associates